MYOS RENS

MYOS NASDAQ
1.300
+0.075
+6.12%
盘后: 1.150 -0.15 -11.54% 18:58 05/24 EDT
开盘
1.230
昨收
1.225
最高
1.310
最低
1.230
成交量
1.27万
成交均量(3M)
4.16万
52周最高
2.500
52周最低
1.040
换手率
0.14%
市值
1,192.19万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供MYOS RENS MYOS股票价格,MYOS RENS股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
展开 >

最近浏览

名称
价格
涨跌幅